Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin AmyloidosisDavid Adams, Ole B. Suhr, Teresa Coelho et al.|New England Journal of Medicine|2018Cited by 2.9k
An International Perspective on Preceding Infections in Guillain-Barré SyndromeSonja E. Leonhard, Soledad Monges, Annemiek A. van der Eijk et al.|Neurology|2022Cited by 85
A multicenter cross-sectional French study of the impact of COVID-19 on neuromuscular diseasesLucie I. Pisella, Shahram Attarian|Orphanet Journal of Rare Diseases|2021Cited by 17
Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndromeRobin C.M. Thomma, Rhys Roberts, Susan K. Halstead et al.|Brain|2025Cited by 9